+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

There's a new layer of drug-industry middlemen that could drive up costs for patients

Nov 23, 2021, 20:13 IST
Business Insider
Crystal Cox/Business Insider

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

Powerful drug-industry middlemen have quietly launched businesses to get better deals from drugmakers. It could drive up costs for patients.

Read our deep dive>>

Beam Therapeutics cofounder David Liu.Jessica Rinaldi/The Boston Globe via Getty Images
As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's

Check it out>>

Advertisement

Patient and doctor.Halfpoint / Getty Images
We asked major health systems to share the promising tech projects they are testing at hospitals. Here are 8 that are taking off.

See more>>

More stories we're reading:

-Leah

Next Article